Evidence generation aligned to the MedTech lifecycle

Driving efficient, compliant, patient‑focused trials

Integrated planning across regulatory, clinical operations, and financial workflows drives stronger MedTech clinical study execution. By aligning regulatory start-up, budgets, site operations, and patient strategies early, sponsors can accelerate timelines, improve site and patient engagement, and maintain compliance and financial control from initiation through close-out.

• Regulatory Strategy & IRB/EC Submissions
  Proactive regulatory strategy and coordinated IRB/EC submissions ensure early alignment with protocol design, reduce approval cycle times, and support global compliance throughout the study lifecycle.
• Contracts & Budgets
  Early collaboration on contract and budget development supports realistic protocol planning and faster site activation. Our experienced contracts team works closely with you to develop Clinical Trial Agreements (CTAs) and budgets aligned with industry expectations, local laws and regulations, and site‑level realities—helping streamline negotiations and reduce cycle times.
• Site Management
  Structured site start-up and ongoing site management promote operational consistency, timely activation, and sustained performance through close-out, helping sites stay aligned with study requirements and milestones.
• Patient Recruitment & Engagement
  Integrated recruitment and engagement planning improves patient identification, enrollment, and retention by aligning operational execution with patient-centric strategies and site workflows.
• Clinical Trial Reimbursement & Billing
  Built-in reimbursement and billing expertise supports financial transparency and compliance, helping mitigate risk, reduce payment delays, and ensure accurate management of patient and site-related costs.
• Monitoring
  Risk-based monitoring strategies provide ongoing oversight of data quality, protocol adherence, and patient safety—supporting proactive issue identification and continuous study optimization.

Safeguarding patients, data, and decisions in medical device trials

An integrated quality and safety framework safeguards patient well‑being, data integrity, and regulatory compliance across the clinical trial lifecycle. Embedded oversight and independent review structures support proactive risk management, informed decision‑making, and confident study execution.

Quality Assurance
Quality assurance services, including FDA inspection readiness, GCP training, site audits, and SOP development, help sponsors and sites proactively manage risk and maintain compliance.

Medical Monitoring
Dedicated medical monitoring provides continuous safety oversight, clinical insight, and real‑time evaluation of emerging risks—supporting patient safety, protocol compliance, and informed sponsor decision‑making.

Clinical Events Committee (CEC)
Independent CEC oversight supports consistent, unbiased adjudication of predefined clinical events, supporting data integrity, endpoint reliability, and regulatory confidence.

Data Safety Monitoring Board (DSMB)
We deliver objective safety and efficacy review at critical milestones, enabling early risk identification, benefit‑risk assessment, and appropriate recommendations to protect patients and study integrity.

Complete clinical development pathway support for MedTech

End‑to‑end clinical support across every stage of MedTech development, from early feasibility through post‑market evidence generation—delivered through flexible engagement models, from full‑service to functional service provider.

Healthy Volunteer / Human Factors
Assess baseline safety, usability, and user interaction to support early device validation.

Feasibility / Pilot Trials
Early first‑in‑human and pre‑market studies designed to evaluate performance and inform study design.

Pivotal Trials
Pre‑market clinical trials conducted to generate evidence required for regulatory approval.

Controlled Post‑Market Trials
Regulated post‑approval studies conducted under defined conditions to meet regulatory or labeling requirements.

Real World Evidence / Observational Registries
Structured data collection within standard clinical practice to support long‑term outcomes and ongoing evidence generation.